4.6 Article

Therapy of ulcus cruris of venous and mixed venous arterial origin with autologous, adult, native progenitor cells from subcutaneous adipose tissue: a prospective clinical pilot study

出版社

WILEY
DOI: 10.1111/jdv.14489

关键词

-

向作者/读者索取更多资源

BackgroundThe stromal vascular fraction (SVF) of adipose tissue consists of cellular subpopulations with distinct regenerative potential. ObjectiveTo investigate the regenerative capacities of autologous SVF cells in the treatment of chronic leg ulcers of venous (VLU) and arterial-venous (AVLU) origin. MethodsMultimorbid ulcer patients received a singular topical treatment with 9-15 x 10(6) SVF cells, separated from abdominal lipoaspirates by digestion with collagenase and neutral protease and applied immediately after isolation. The primary endpoints were the change in wound size 12 weeks after treatment and evaluation of adverse events. Secondary endpoints included the time to complete wound epithelialization and change in pain levels. Postoperative wound treatment modalities and treatment of comorbidities were not intensified compared with pre-operative management. Follow-up period was at least 6 months. ResultsSixteen elderly ulcer patients (seven with VLU, nine with AVLU) were treated as described. All VLU patients (median ulcer size: 48.25 cm(2)) and four of nine AVLU patients showed complete epithelialization of the ulcers within 71-174 days. In three patients with large ulcerations on both legs, ulcerations on the non-treated, contralateral leg also epithelialized. Patients reported a considerable rapid decrease in pain intensity by 2.5 points on average on a visual scale from 1 to 5 within the first 2 weeks after treatment. The patients were followed up for 9-44 months (median: 30 months). No severe side-effects were observed. ConclusionsThe use of SVF cells presents an effective, minimally invasive option for the treatment of VLU and AVLU even in multimorbid patients. In patients with larger predominantly ischaemic AVLU and comorbidities, one-time application of the used amounts of SVF cells was not sufficient in the majority of cases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Allergy

Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines

Ioana Agache, Yang Song, Margarita Posso, Pablo Alonso-Coello, Claudio Rocha, Ivan Sola, Jessica Beltran, Cezmi Akdis, Mubeccel Akdis, Knut Brockow, Tomas Chivato, Stefano del Giacco, Thomas Eiwegger, Kilian Eyerich, Ana Gimenez-Arnau, Jan Gutermuth, Emma Guttman-Yassky, Marcus Maurer, Graham Ogg, Peck Y. Ong, Liam O'Mahony, Jurgen Schwarze, Thomas Werfel, Carlos Canelo-Aybar, Oscar Palomares, Marek Jutel

Summary: This review evaluated the efficacy, safety, and economic impact of dupilumab compared to standard care for uncontrolled moderate-to-severe atopic dermatitis. Dupilumab showed significant improvements in symptoms and quality of life for both adult and adolescent patients. Long-term safety data is needed for both children and adults, along with more efficacy data for the pediatric population.

ALLERGY (2021)

Article Allergy

EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old

Ioana Agache, Cezmi Akdis, Mubeccel Akdis, Knut Brockow, Tomas Chivato, Stefano del Giacco, Thomas Eiwegger, Kilian Eyerich, Ana Gimenez-Arnau, Jan Gutermuth, Emma Guttman-Yassky, Marcus Maurer, Graham Ogg, Peck Y. Ong, Liam O'Mahony, Juergen Schwarze, Amena Warner, Thomas Werfel, Oscar Palomares, Marek Jutel

Summary: Chronic spontaneous urticaria (CSU) poses a significant burden on patients, families and healthcare systems, but a stratified approach to management supported by better understanding of mechanisms allows for targeted treatment with omalizumab.

ALLERGY (2022)

Editorial Material Dermatology

Screening for Body Dysmorphic Disorder among Patients Seeking Dermatological and Cosmetic Care: A Cross-sectional Study

Valerie PEETERS, Sherief R. JANMOHAMED, Samira BAHARLOU, Jan GUTERMUTH, Ria WILLEMSEN

ACTA DERMATO-VENEREOLOGICA (2021)

Review Allergy

T-cell subsets in the skin and their role in inflammatory skin disorders

Inge Kortekaas Krohn, Joeri L. Aerts, Karine Breckpot, Cleo Goyvaerts, Edward Knol, Femke Van Wijk, Jan Gutermuth

Summary: T lymphocytes play a crucial role in the adaptive immune response, with different subsets exhibiting specific functions in a variety of inflammatory skin disorders. Some T-cell subsets show similarities or opposing functions across different skin diseases.

ALLERGY (2022)

Article Dermatology

Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo-controlled, randomized, phase III clinical trial (ECZTRA 7)

J. Gutermuth, A. E. Pink, M. Worm, L. Soldbro, C. Bjerregard Oland, S. Weidinger

Summary: The study evaluated the efficacy and safety of tralokinumab plus TCS in adult patients with severe AD not adequately controlled with CSA or with contraindications to oral CSA, showing the treatment was effective and well tolerated.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Dermatology

Development of a patient-reported experience measure for chronic inflammatory skin diseases

E. Van den Steen, D. Ramaekers, M. Horlait, J. Gutermuth

Summary: This study aimed to identify relevant items for patient's experience in immunodermatology and develop a concise questionnaire to assess patient's experience in routine clinical care. By conducting a literature search, patient interviews, and a multi-stakeholder focus group, a Patient-Reported Experience Measure (PREM) questionnaire with 11 items was developed. This user-friendly tool can be used in scientific and routine care settings to improve care for patients with chronic inflammatory skin diseases.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

Letter Dermatology

Resolution of idiopathic erythema gyratum repens with acitretin

S. Nguyen, E. van de Perre, B. Velkeniers, L. Pierret, J. Gutermuth, M. Grosber

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

Review Immunology

Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases

Yves Piette, Valerie Reynaert, Amber Vanhaecke, Carolien Bonroy, Jan Gutermuth, Alberto Sulli, Maurizio Cutolo, Vanessa Smith

Summary: This systematic review examines the value of nailfold videocapillaroscopy (NVC) in idiopathic inflammatory myopathies (IIM). The study finds significant differences in NVC outcomes between (juvenile) dermatomyositis, other inflammatory myopathies, healthy controls, and systemic sclerosis patients. Reduced capillary density and scleroderma pattern appear to be associated with active disease in (juvenile) dermatomyositis, while immunosuppressive treatment seems to reduce NVC abnormalities.

AUTOIMMUNITY REVIEWS (2022)

Article Immunology

A Novel Method for Total IgE Purification from Human Serum

Fariza Mishaal Saiema Badloe, Shauni De Vriese, Tina De Bruyn Carlier, Elise Vandersichel, Joerg Scheffel, Marcus Maurer, Johannes Ring, Jan Gutermuth, Inge Kortekaas Krohn

Summary: In this study, a novel method for the purification of total IgE from human serum was established using specific antibodies and beads, resulting in high purity of IgE. This highly effective and widely accessible approach can improve the use of IgE-based models and contribute to allergy research.

JOURNAL OF IMMUNOLOGY (2022)

Article Dermatology

Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis

Jonathan Silverberg, David N. Adam, Matthew Zirwas, Sunil Kalia, Jan Gutermuth, Andreas Pinter, Andrew E. Pink, Andrea Chiricozzi, Sebastien Barbarot, Thomas Mark, Ann-Marie Tindberg, Stephan Weidinger

Summary: This study analyzed the efficacy and safety of tralokinumab combined with topical corticosteroids in the treatment of atopic dermatitis. The results showed that continued tralokinumab treatment plus corticosteroids provided progressive and sustained improvements in AD signs, symptoms, and health-related quality of life over 32 weeks period.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)

Review Geriatrics & Gerontology

The effect of resistance exercise on the immune cell function in humans: A systematic review

Lene Salimans, Keliane Liberman, Rose Njemini, Inge Kortekaas Krohn, Jan Gutermuth, Ivan Bautmans

Summary: This review provides a systematic analysis of the impact of resistance exercise on immune cells in the blood circulation. The findings suggest that resistance exercise activates specific signaling pathways in immune cells and improves antioxidant enzyme expression. Additionally, there are age-related differences in natural killer cell activity after resistance exercise.

EXPERIMENTAL GERONTOLOGY (2022)

Article Dermatology

Initiating value-based healthcare in psoriasis: Proposing a value-based outcome set for daily clinical practice

Niels Timo Hilhorst, Elfie Deprez, Deepak Mukesh Wieshwaykumar Balak, Nanja Van Geel, Jan Gutermuth, Isabelle Hoorens, Jo Lydie Wilfried Lambert

Summary: This study aims to develop an actionable value-based outcome set (VOS) for evaluating psoriasis care. Through four phases of a mixed method approach, the study identified the outcomes deemed important by patients and selected suitable instruments to measure these outcomes. This VOS allows for the evaluation and improvement of current care processes, increasing value for patients.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Review Dermatology

Nipple eczema: A systematic review and practical recommendations

V Reynaert, J. Gutermuth, A. Wollenberg

Summary: The nipple is an important part of the human breast and serves various purposes. Nipple eczema can have negative effects on the patient's quality of life. This article discusses the different types of nipple eczema and provides information on diagnosis and treatment options.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Letter Dermatology

JAK1/2 pathway-specific treatment of disseminated granuloma annulare with baricitinib

A. Jadoul, L. Huygen, G. Leemans, M. Grosber, I. Kortekaas Krohn, J. Gutermuth

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Letter Dermatology

Acute generalized exanthematous pustulosis in a patient with COVID-19 infection

L. De Brucker, L. Seyler, G. Leemans, J. Gutermuth, M. Grosber

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

暂无数据